Article Details

I-Mab reports efficacy of Anti-CD47 monoclonal Ab on relapsed/refractory malignancy

Retrieved on: 2020-11-25 10:30:00

Tags for this article:

Click the tags to see associated articles and topics

I-Mab reports efficacy of Anti-CD47 monoclonal Ab on relapsed/refractory malignancy. View article details on hiswai:

Excerpt

... of lemzoparlimab (Highly Differentiated Anti-CD47 <b>Monoclonal Antibody</b>) ... severe anemia -- common toxicity of CD47 antibodies of the same class.

Article found on: www.biospectrumasia.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up